RICERCA ITALIANA     

Programmi di ricerca simili:

• 1 - Basi molecolari, aspetti fisiopatologici e terapeutici delle malattie lisosomiali
• 2 - Patogenesi molecolare ed analisi sequenziale di interazioni cellulari e marcatori biologici di progressione di malattia e di resistenza al trattamento nella leucemia linfatica cronica
• 3 - Eritropoiesi normale e patologica: caratterizzazione molecolare mediante tecnologie avanzate a resa elevata.
• 4 - Basi genetiche e molecolari della patogenicità batterica
• 5 - Meccanismi della citochinesi: identificazione di nuovi geni coinvolti nel processo e nella sua regolazione
• 6 - CONTROLLO POST-TRASCRIZIONALE DELL'ESPRESSIONE GENICA, SUE ALTERAZIONI NELLE PATOLOGIE DELL'UOMO E TRATTAMENTI TERAPEUTICI MIRATI
• 7 - Intolleranza alle proteine con lisinuria: sviluppo ed analisi di un modello genetico murino di tipo condizionale e di modelli cellulari umani
• 8 - Un approccio integrato allo studio della eziopatogenesi delle mitocondriopatie
• 9 - ANALISI DEI MECCANISMI DI SOPRAVVIVENZA CELLULARE DI EUCARIOTI MEDIANTE STRATEGIE DI PROTEOMICA
• 10 - Aspetti biochimici e genetici del disturbo autistico.

Classificazione scientifico-disciplinare

• Area scientifico disciplinare: Scienze mediche
  • GENETICA MEDICA
  • NEUROLOGIA

Classificazione brevettuale

• CHEMISTRY; METALLURGY
  • BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF (biocides, pest repellants or attractants, or plant growth regulators, containing micro-organisms, viruses, microbial fungi, enzymes, fermentates or substances produced by or extracted from micro-organisms or animal material A01N63/00; food compositions A21, A23; medicinal preparations A61K; chemical aspects of, or use of materials for, bandages, dressings, absorbent pads or surgical articles A61L; fertilisers C05); PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS (preservation of living parts of humans or animals A01N1/02); MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (micro-biological testing media C12Q)

Classificazione geografica

• Regione: Lombardia

Bibliografia

Alvarez-Buylla A. Neurogenesis and plasticity in the CNS of adult birds. Exp. Neurol. 1992, 115(1), 110–114.
Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. J. Neurosci. 2002 22(3), 629–634 .
Anderson DJ, Gage FH, Weissman IL. Can stem cells cross lineage boundaries? Nature Med. 2001 7(4), 393–395
Azzouz M, Ralph GS, Storkebaum E et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004 429(6990), 413–417.
Brockington A, Kirby J, Eggitt D, Schofield E, Morris C, Lewis CE, Ince PG, Shaw PJ. Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis. Neurogenetics. 2005 May;6(2):101-4.
Chen YZ, Bennett CL, Huynh HM, et al., . DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004 Jun;74(6):1128-35.
Clement AM, Nguyen MD, Roberts EA et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003 302(5642): 113–117.
Corti S, Locatelli F, Papadimitriou D, et al. Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1. Hum Mol Genet. 2006 Jan 15;15(2):167-87.
Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells. (2005) [Epub ahead of print]
Corti S, Locatelli F, Papadimitriou D, et al. Multipotentiality, homing properties, and pyramidal neurogenesis of CNS-derived LeX(ssea-1)+/CXCR4+ stem cells. FASEB J 2005 19:1860-2.
Corti S, Locatelli F, Donadoni C, et al. Wild-type bone marrow cells ameliorate the phenotype of SOD1-G93A ALS mice and contribute to CNS, heart and skeletal muscle tissues. Brain 2004 127(Pt 11):2518-32
Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP.Vascular endothelial growth factor gene variability is associated with increased risk for AD.
Ann Neurol. 2005 Mar;57(3):373-80.
Del Bo R., Bonato S., Rossetti G., Ghezzi S., Corti S., Bresolin N., Carnelli V., Comi G.P. A novel missense mutation of IGHMBP2 gene in an Italian infant with spinal muscular atrophy with respiratory distress type 1. XXXVI Congress of the Italian Neurological Society, Cernobbio (CO), 8-12 ottobre 2005. Neurological Sciences, vol. 26, supplemento, pp S340, 2005
Deng HX, Hentati A, Tainer JA, Iqbal Z, Cayabyab A, Hung WY, Getzoff ED, Hu P, Herzfeldt B, Roos RP, et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science. 1993 Aug 20;261(5124):1047-51.
Devon RS, Helm JR, Rouleau GA, Leitner Y, Lerman-Sagie T, Lev D, Hayden MR. The first nonsense mutation in alsin results in a homogeneous phenotype of infantile-onset ascending spastic paralysis with bulbar involvement in two siblings. Clin Genet. 2003 Sep;64(3):210-5.
Eymard-Pierre E, Lesca G, Dollet S, Santorelli FM, di Capua M, Bertini E, Boespflug-Tanguy O. Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am J Hum Genet. 2002 Sep;71(3):518-27.
Greenway MJ, Andersen PM, Russ C, et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet. 2006 Apr;38(4):411-3.
Grohmann K, Schuelke M, Diers A, et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet. 2001 Sep;29(1):75-7
Gros-Louis F., Meijer I.A., Hand C.K et al. An ALS2 gene mutation causes hereditary spastic paraplegia in a Pakistani kindred, Ann. Neurol. 2003 53:144–145.
Gros-Louis F., Laurent S., Lopes A.A., et al. Absence of mutations in the hypoxia response element of VEGF in ALS, Muscle Nerve 2003 28:774–775.
Hess DA, Wirthlin L, Craft TP, Herrbrich PE, Hohm SA, Lahey R, Eades WC, Creer MH, Nolta JA. Selection based on CD133 and high aldehyde dehydrogenase activity isolates long-term reconstituting human hematopoietic stem cells. Blood. 2006 Mar 1;107(5):2162-9.
Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science 2003 301(5634), 839–842.
Klein SM, Behrstock S, McHugh J et al. GDNF delivery using human neural progenitor cells in a rat model of ALS. Hum. Gene. Ther. 2005 16(4), 509–521.
Lambrechts D, Storkebaum E, Morimoto M, Del-Favero J, Desmet F, Marklund SL, Wyns S, Thijs V, Andersson J, van Marion I, Al-Chalabi A, Bornes S, Musson R, Hansen V, Beckman L, Adolfsson R, Pall HS, Prats H, Vermeire S, Rutgeerts P, Katayama S, Awata T, Leigh N, Lang-Lazdunski L, Dewerchin M, Shaw C, Moons L, Vlietinck R, Morrison KE, Robberecht W, Van Broeckhoven C, Collen D, Andersen PM, Carmeliet P. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet. 2003 Aug;34(4):383-94.
Locatelli F, Corti S, , Papadimitriou D, et al. siRNA Mediated Interference of Motoneuron Death Triggered by Fas in SOD1 G93A ALS Mouse Model. American Academy of Neurology 2006
Li XJ, Du ZW, Zarnowska ED et al. Specification of motoneurons from human embryonic stem cells. Nature Biotechnol. 23(2), 215–221 2005.
Miller T. et al., Targeting Neurodegenerative Disease with Antisense Oligonucleotides, American Academy of Neurology 2006
Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986 Apr;36(4):511-7.
Oosthuyse B, Moons L, Storkebaum E et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001 Jun;28(2):131-8.
Panzeri C, De Palma C, Martinuzi A, Daga A, De Polo G, Bresolin N, Miller CC, EL Tudor E Clementi, Bassi MT. The first ALS2 missense mutation associated with JPLS reveals new aspects of alsin biological function, Brain 2006 (In press).
Ralph GS, Radcliffe PA, Day DM et al. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nature Med. 2005 11(4), 429–433
Raoul C, Abbas-Terki T, Bensadoun JC et al. Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nature Med. 2005 11(4), 423–428
Storkebaum E, Lambrechts D, Dewerchin M et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nature Neurosci. 2005 8(1), 85–92.
Tandan R. and Bradley W.G. Amyotrophic lateral sclerosis: Part 1. Clinical features, pathology, and ethical issues in management, Ann. Neurol. 1985 18: 271–280.
Terry PD, Kamel F, Umbach DM, Lehman TA, Hu H, Sandler DP, Taylor JA. VEGF promoter haplotype and amyotrophic lateral sclerosis (ALS). J Neurogenet. 2004 Apr-Jun;18(2):429-34
Topp JD, Gray NW, Gerard RD, Horazdovsky BF. Alsin is a Rab5 and Rac1 guanine nucleotide exchange factor. J Biol Chem. 2004 Jun 4;279(23):24612-23.
Yamanaka K, Vande Velde C, Eymard-Pierre E, Bertini E, Boespflug-Tanguy O, Cleveland DW. Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):16041-6.
Yamanaka K et al., Selective Gene Ablation of Mutant SOD1 in Microglia Significantly Slows Disease Progression of ALS, American Academy of Neurology 2006
Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002 110(3), 385–397 .
Yang Y, Hentati A, Deng HX, et al. The gene encoding alsin, a protein with three guanine–nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001 Oct;29(2):160-5.

Parole Chiave

MALATTIE DEL MOTONEURONE, SCLEROSI LATERALE AMIOTROFICA, NEURODEGENERAZIONE, DIAGNOSI MOLECOLARE, PATOGENESI MOLECOLARE, CELLULE STAMINALI, TERAPIA GENICA, MODELLI ANIMALI, PROTEINE INTERATTRICI